Therapeutic options for a nulliparous young woman with a giant intramural uterine myoma

Authors

Keywords:

myoma, fibroid, goserelin, therapeutic embolization, uterine myomectomy.

Abstract

Introduction: Uterine leiomyomas are the most common benign gynecological tumors; they are a cause of anemia, infertility, altered embryo implantation, recurrent gestational loss, premature delivery and urinary incontinence. Their malignant transformation is exceptional. Fertility impairment is associated with myomas in between 3 % and 31 % and depends on their location and size, especially in those that distort the uterine cavity.
Objective: To describe the therapeutic options for a nulliparous girl with a giant intramural uterine fibroid.
Clinical Case: A 30-year-old patient with a 5-year history of intramural uterine fibroid, in addition to iron deficiency anemia. She complains of heavy and painful periods, urinary incontinence and constipation. Treatment was staggered, using goserelin acetate, selective embolization of the uterine arteries, and subsequent myomectomy.
Conclusions: The treatment of uterine fibroid in young, nulliparous women depends on the size, location, associated symptoms, age of the patient and desire to have offspring.

Downloads

Download data is not yet available.

Author Biography

Antonio Belaunde Clausell, Hospital Dr. Carlos J. Finlay

Especialista de Primer Grado de Medicina Interna.

Profesor Instructor

References

1. Hernández Valencia M, Valerio Castro E, TerceroValdez Zúñiga CL, Barrón Vallejo J, Luna Rojas RM. Miomatosis uterina: implicaciones en salud reproductiva. Ginecol Obstet Mex. 2017 [acceso: 20/07/2021]; 85(9):611-633. Disponible en: https://www.medigraphic.com/pdfs/ginobsmex/gom-2017/gom179h.pdf

2. Sepúlveda AJ, Alarcón NMA. Manejo médico de la miomatosis uterina. Revisión de la literatura. Rev. Chil. Obstet. Ginecol. 2016 [acceso: 20/07/2021]; 81(1):48-55. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262016000100009&lng=es

3. Wise LA, Laughlin Tommaso SK. Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clini Obstetrics and Gynecology. 2016 [acceso: 20/07/2021]; 59(1):2-24. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733579/

4. Ortiz Ruiz ME, Matute Labrador A, Martínez Consuegra N. Miomatosis uterina. An Med (Mex). 2009 [acceso: 20/07/2021]; 54 (4): 222-233. Disponible en: https://www.medigraphic.com/pdfs/abc/bc-2009/bc094h.pdf

5. Pier BD, Bates GW. Potential causes of subfertility in patients with intramural fibroids. Fertility Research and Practice. 2015 [acceso: 20/07/2021]; 1:12. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424315/

6. Causa Andrieu PI, Couture JM, Benítez Mendes AC, Napoli N, Chacón CRB, Ulla M. Infertilidad en la mujer: importancia del análisis combinado de los métodos por imágenes. Reporte de casos. Ginecol Obstet Mex. 2017 [acceso: 20/07/2021]; 85(12):846-852. Disponible en: https://www.medigraphic.com/pdfs/ginobsmex/gom-2017/gom1712i.pdf

7. Fábregues F, Peñarrubia J. Mioma uterino. Manifestaciones clínicas y posibilidades actuales de tratamiento conservador. Med Integral. 2002 [acceso: 20/07/2021]; 40(5):190-195. Disponible en: https://www.elsevier.es/es-revista-medicina-integral-63-articulo-mioma-uterino-manifestaciones-clinicas-posibilidades-13036877

8. Sequeiro Rojas LA, Montero Alfaro A. Miomatosis uterina en una mujer joven, nulípara. (Reporte de caso y revisión bibliográfica). Revista Médica de Costa Rica y Centroamérica. 2007 [acceso: 20/07/2021]; 64(579):71-75. Disponible en: https://www.binasss.sa.cr/revistas/rmcc/579/art3.pdf

9. Elkafas H, Al Helou M, Yang Q, Al-Hendy A. Medical options for uterine fibroids in the context of reproduction. En: Botros RMBR, Yakoub Khalaf, Mostafa AB/Editor del libro. Fibroids an reproduction. First Edition. Boca Raton: CRC Press; 2021.p. 55-70.

10. De Falco M, Staibano S, Mascolo M, Mignogna C, Improda L, Ciociola, F, et al. Leiomyoma pseudocapsule after presurgical treatment with gonadotropin releasing hormone agonists: relatioship betwen clinical features and immunohistochemical changes. Eur J Obstet Gynecol Reprod boil. 2019 [acceso: 20/07/2021]; 144(1):44-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19297072/

11. Mateo León C. Microesferas poliméricas para tratamiento local. [Tesis de Especialidad]. Santa Cruz de Tenerife, España: Universidad de la Laguna; 2019. [acceso: 20/07/2021]. Disponible en: https://riull.ull.es/xmlui/bitstream/handle/915/20008/Microesferas%20polimerica-s%20para%-20tratamiento%20local.pdf?sequence=1

12. Salazar Herrera CP. Riesgos y beneficios de los análogos de GNRH y resultado postquirúrgico en miomatosis uterina. [Tesis de Especialidad]. Guayaquil, Ecuador: Universidad de Guayaquil; 2019[acceso: 20/07/2021]. Disponible en: http://repositorio.ug.edu.ec/handle/redug/46618

13. Ravina JH, Herbreteau D, Ciraru Vigneron N, Bouret JM, Houdart E, Aymard A, et al. Arterial embolization to treat uterine myomata. Lancet. 1995 [acceso: 20/07/2021]; 346(8976):671-2. Disponible en: https://pubmed.ncbi.nlm.nih.gov/7544859/

14. de la Cruz de Oña A, Vázquez Luna F, Roque González R. Embolización de arterias uterinas para el tratamiento de fibromas uterinos sintomáticos. Revista Cubana de Obstetricia y Ginecología. 2020 [acceso: 20/07/2021]; 46(1):e537. Disponible en: http://revginecobstetricia.sld.cu/index.php/gin/article/view/537

15. Czuczwar P, Stepniak A, Milart P, Paszkowski T, Wozniak S. Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve - an observational study. J Ovarian Res. 2018 [acceso: 20/07/2021]; 11(1):45. Disponible en. https://pubmed.ncbi.nlm.nih.gov/29859107/

Downloads

Published

2022-04-02

How to Cite

1.
González Sánchez R, Romero Reinaldo Y, Belaunde Clausell A. Therapeutic options for a nulliparous young woman with a giant intramural uterine myoma. Rev Cubana Med Milit [Internet]. 2022 Apr. 2 [cited 2025 Jan. 9];51(2):e02201650. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/1650

Issue

Vol. 51 No. 2 (2022): April - June

Section

Case Presentation

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.

Most read articles by the same author(s)

1 2 > >>